Chemotherapy for breast cancer during pregnancy: An 18-year experience from five London teaching hospitals

Journal of Clinical Oncology

Volumn 23, Issue 18, 2005, Pages 4192-4197

  Ring, Alistair E ^a   Smith, Ian E ^a   Jones, Alison ^a   Shannon, Catherine ^a   Galani, Eleni ^a   Ellis, Paul A ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL PRACTICE; DRUG TOLERABILITY; FEMALE; FIRST TRIMESTER PREGNANCY; HISTOPATHOLOGY; HUMAN; METASTASIS; PALLIATIVE THERAPY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; SPONTANEOUS ABORTION; TEACHING HOSPITAL; BREAST TUMOR; CLINICAL TRIAL; MULTICENTER STUDY; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RETROSPECTIVE STUDY; UNITED KINGDOM;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; LONDON; METHOTREXATE; NEOADJUVANT THERAPY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 23044486784     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.038     Document Type: Article

References (36)

1. Wallack MK, Wolf JA Jr, Bedwinek J, et al: Gestational carcinoma of the female breast. Curr Probl Cancer 7:1-58, 1983
2. Ventura SJ: First births to older mothers, 1970-1986. Am J Public Health 79:1675-1677, 1989
3. Ranstam J, Janzon L, Olsson H: Rising incidence of breast cancer among young women in Sweden. Br J Cancer 61:120-122, 1990
4. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for breast cancer: An overview of the randomised trials. Lancet 352: 930-942, 1998
5. Singletary SE, Allred C, Ashley P, et al: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:3628-3636, 2002
6. Lubchenco LO, Hansman C, Dressler M, et al: Intrauterine growth as estimated from liveborn birth-weight data at 24 to 42 weeks of gestation. Pediatrics 32:793-800, 1963
7. Giacalone PL, Laffargue F, Benos P: Chemotherapy for breast carcinoma during pregnancy: A French national survey. Cancer 86: 2266-2272, 1999
8. Berry DL, Theriault RL, Holmes FA, et al: Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 17: 855-861, 1999
9. Gwyn K, Theriault R, Sahin A, et al: Treatment of breast cancer during pregnancy using a standard protocol: Update of the M.D. Anderson experience. Proc Am Soc Clin Oncol, 20:18b, 2001 (abstr 1821)
10. Middleton LP, Amin M, Gwyn K, et al: Breast carcinoma in pregnant women: Assessment of clinicopathologic and immunohistochemical features. Cancer 98:1055-1060, 2003
11. Ishida T, Yokoe T, Kasumi F, et al: Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: Analysis of case-control study in Japan. Jpn J Cancer Res 83:1143-1149, 1992
12. Zemlickis D, Lishner M, Degendorfer P, et al: Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 166:781-787, 1992
13. Bonnier P, Romain S, Dilhuydy JM, et al: Influence of pregnancy on the outcome of breast cancer: A case-control study-Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer 72:720-727, 1997
14. Li CI, Daling JR, Malone KE: Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 21:28-34, 2003
15. Aziz S, Pervez S, Khan S, et al: Case control study of novel prognostic markers and disease outcome in pregnancy/lactation-associated breast carcinoma. Pathol Res Pract 199:15-21, 2003
16. Nicholson HO: Cytotoxic drugs in pregnancy: Review of reported cases. J Obstet Gynaecol Br Commonw 75:307-312, 1968
17. Gililland J, Weinstein L: The effects of cancer chemotherapeutic agents on the developing fetus. Obstet Gynecol Surv 38:6-13, 1983
18. Doll DC, Ringenberg QS, Yarbro JW: Antineoplastic agents and pregnancy. Semin Oncol 16:337-346, 1989
19. Schapira DV, Chudley AE: Successful pregnancy following continuous treatment with combination chemotherapy before conception and throughout pregnancy. Cancer 54:800-803, 1984
20. Zemlickis D, Lishner M, Degendorfer P, et al: Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 152:573-576, 1992
21. Cuvier C, Espie M, Extra JM, et al: Vinorelbine in pregnancy. Eur J Cancer 33:168-169, 1997
22. Sood AK, Shahin MS, Sorosky JI: Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol 83: 599-600, 2001
23. De Santis M, Lucchese A, De Carolis S, et al: Metastatic breast cancer in pregnancy: First case of chemotherapy with docetaxel. Eur J Cancer Care (Engl) 9:235-237, 2000
24. Losch A, Lahodny J, Petru E: Possible influence of granulocyte colony-stimulating factor and recombinant human erythropoietin on human chorionic gonadotropin secretion during chemotherapy for choriocarcinoma. Gynecol Oncol 83:165-166, 2001
25. Muller T, Hofmann J, Steck T: Eclampsia after polychemotherapy for nodal-positive breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 67:197-198, 1996
26. Stoll BJ, Kliegman RM: The high risk infant, in, Behrman RE, Kliegman RM, Jenson HB (eds): Nelson Textbook of Pediatrics, 16th Edition. Philadelphia, PA, WB Saunders Company, 2000, pp 474-485
27. Murray NA, Acolet D, Deane M, et al: Fetal marrow suppression after maternal chemotherapy for leukaemia. Arch Dis Child Fetal Neonatal Ed 17:F209-F210, 1994 (suppl)
28. Reynoso EE, Shepherd FA, Messner HA, et al: Acute leukemia during pregnancy: The Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 5:1098-1106, 1987
29. Partridge AH, Garber JE: Long-term outcomes of children exposed to amineoplastic agents in utero. Semin Oncol 27:712-726, 2000
30. Aviles A, Neri N: Hematological malignancies and pregnancy: A final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2:173-177, 2001
31. Gaillard B, Leng JJ, Grellet J, et al: Transplacental passage of epirubicin [in French]. J Gynecol Obstet Biol Reprod (Paris) 24:63-68, 1995
32. Karp GI, von Oeyen P, Valone F, et al: Doxorubicin in pregnancy: Possible transplacental passage. Cancer Treat Rep 67:773-777, 1983
33. Turchi JJ, Villasis C: Anthracyclines in the treatment of malignancy in pregnancy. Cancer 61:435-440, 1988
34. Garber JE: Long-term follow-up of children exposed in utero to antineoplastic agents. Semin Oncol 16:437-444, 1989
35. Meyer-Wittkopf M, Barth H, Emons G, et al: Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: Case report and review of the literature. Ultrasound Obstet Gynecol 18:62-66, 2001
36. German Breast Group, GBG-29: Breast cancer in pregnancy: Prospective register study for the diagnosis and treatment of breast cancer in pregnancy. http://www.germanbreastgroup.de/ pregnancy